Yigal Nochomovitz analyst CITI

Currently out of the existing stock ratings of Yigal Nochomovitz, 82 are a HOLD (19.29%), 323 are a BUY (76%), 20 are a SELL (4.71%).

Yigal Nochomovitz

Work Performance Price Targets & Ratings Chart

Analyst Yigal Nochomovitz works at CITI with a stock forecast success ratio of 48.57% fulfilled within 163.94 days on average.

Yigal Nochomovitz’s has documented 829 price targets and ratings displayed on 48 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on APLT, Applied Therapeutics at 16-Feb-2024.

Wall Street Analyst Yigal Nochomovitz

Analyst best performing recommendations are on CRBU (CARIBOU BIOSCIENCES).
The best stock recommendation documented was for CRBU (CARIBOU BIOSCIENCES) at 8/17/2021. The price target of $27 was fulfilled within 1 day with a profit of $2.7 (11.11%) receiving and performance score of 111.11.

Average potential price target upside

AERI Aerie Pharmaceuticals . ALDX Aldeyra The APLS Apellis Pharmaceuticals ARCT Arcturus Therapeutics Holdings ARDX Ardelyx ARVN Arvinas ATRA Atara Biotherapeutics CLLS Cellectis SA CRBU Caribou Biosciences CRSP Crispr Therapeutics AG DRNA Dicerna Pharmaceuticals EIGR Eiger Biopharmaceuticals FATE Fate Therapeutics HARP Harpoon Therapeutics IMRA Imara IPHA Innate Pharma LXRX Lexicon Pharmaceuticals MGNX MacroGenics MRTX Mirati Ther MRUS Merus BV ORIC Oric Pharmaceuticals  OVID Ovid Therapeutics PBYI Puma Biotechnology PRQR ProQR Therapeutics BV PTLA Portola Pharmaceuticals RARE Ultragenyx RETA Reata Pharmaceuticals RIGL Rigel Pharmaceuticals UBX Unity Biotechnology XLRN Acceleron Pharma ZLAB Zai Lab Ltd ZYME Zymeworks . Common Stock APLT Applied Therapeutics CALT Calliditas Therapeutics GRTX Galera Therapeutics RCUS Arcus Biosciences CMRX Chimerix OPT Opthea Ltd SNDX Syndax Pharmaceuticals SYBX Synlogic RAIN Rain Therapeutics NCNA NuCana PLC BMEA Biomea Fusion IDYA Ideaya Biosciences STTK Shattuck Labs  RLYP Relypsa BGNE BeiGene Ltd GRCL Gracell Biotechnologies .

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

14

$-1.25 (-8.20%)

13

1 years 5 months 25 days ago

1/6 (16.67%)

$-1.07 (-7.10%)

176

Buy

13

$-2.25 (-14.75%)

1 years 5 months 30 days ago

0/2 (0%)

$-2.18 (-14.36%)

Hold

20

1 years 5 months 30 days ago

0/1 (0%)

$14.21 (245.42%)

Buy

15.25

27

1 years 6 months ago

8/13 (61.54%)

$0.09 (0.59%)

136

Hold

15.25

30

1 years 6 months ago

1/3 (33.33%)

$0.09 (0.59%)

48

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Yigal Nochomovitz is most bullish on?

Potential upside of $131.22 has been obtained for BGNE (BEIGENE LTD)

Which stock is Yigal Nochomovitz is most reserved on?

Potential downside of -$9.96 has been obtained for HARP (HARPOON THERAPEUTICS)

What Year was the first public recommendation made by Yigal Nochomovitz?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?